The applications of the artificial intelligence (AI) They go far beyond what models such as Chatgpt, Deepseek or Dall-E offer us, among many others. These services are already part of the day -to -day life of many people, but AI is present in many other areas in which is already making a differencesuch as The design of new materialsthe development of drugs or medical diagnosis. The innovation in which we are about to investigate belongs to this last scenario of use.
And it is that the Damo Academy, which is the branch dedicated to the investigation of the gigantic Chinese company Alibaba, has developed an AI tool that is capable of detecting in an early phase and in asymptomatic patients one of the types of cancer with the worst prognosis: that of pancreas. The figures of this disease are shocking. Is The seventh cause of cancer death globally even though the twelfth type of this most frequent evil. And survival after diagnosis, unfortunately, does not exceed 10%.
The FDA is accelerating the approval of this Alibaba technology
When the protagonist is the health of the people it is encouraging to verify that two superpowers faced with The virulence with which they are Currently USA and China are able to leave their differences aside. The first contact with AI developed by the Damo Academy to identify pancreas cancer in November 2023 thanks to an article published in the Medicine magazine Nature Medicine.
Some treatments have taken between 10 and 12 years to be approved by the relevant agencies
The approval of an innovation of these characteristics by the European Medicines Agency, known as EMA for its English denomination (European Medicines Agency), or the FDA (Food and Drug Administration) of the USA, requires investing a lot of time. Some treatments have taken between 10 and 12 years to be approved if we count the time elapsed from the moment the initial idea arose until it received the final blessing from these agencies. However, this alibaba presumably will be able to be used with patients in much less time.
And is that, according to SCMPthe FDA has initiated the process of accelerated review and approval of Panda (Pancreatic Cancer Detection with Artificial Intelligence), which is what is the name of the model developed by Alibaba. This deep learning model It has been trained with computerized abdominal tomographies without contrast of 3,208 patients with pancreatic cancer. And, according to preliminary tests, it is 34.1% more sensitive than radiologists when identifying this disease. Alibaba has already used Panda to examine 40,000 people in a hospital in NOBO (China), and identified six cases of early pancreatic cancer. Two of them were overlooked by radiologists during routine exams.
Image | MART PRODUCTION
More information | Nature Medicine | SCMP
In Xataka | We did not know why some superbacteria were resistant to antibiotics. This AI has found it in two days
GIPHY App Key not set. Please check settings